DMAC

Company Overview DiaMedica Therapeutics is a clinical-stage biopharmaceutical company focused on treatments for preeclampsia, fetal growth restriction, and acute ischemic…

DiaMedica Therapeutics Inc (NASDAQ: DMAC) Q1 2022 Earnings Conference

DiaMedica Therapeutics Inc (NASDAQ: DMAC) Q4 2021 Earnings Conference

DiaMedica Therapeutics Inc (NASDAQ: DMAC) Q3 2021 Earnings Conference

DiaMedica Therapeutics inc (NASDAQ: DMAC) Q2 2021 Earnings Conference

DiaMedica Therapeutics inc (NASDAQ: DMAC) Q4 2020 Earnings Conference